Prediction of Alzheimer’s Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status-Reference-Cited by-同舟云学术

Prediction of Alzheimer’s Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status

Published:2017-11-28 Issue:1 Volume:61 Page:373-388
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Lange Catharina¹²,Suppa Per¹³,Pietrzyk Uwe²⁴,Makowski Marcus R.⁵,Spies Lothar³,Peters Oliver⁶,Buchert Ralph¹⁷,

Affiliation:

1. Department of Nuclear Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany

2. School of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany

3. jung diagnostics GmbH, Hamburg, Germany

4. Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany

5. Department of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany

6. Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Berlin, Germany

7. Department of Diagnostic and Interventional Radiology and Nuclear Medicine, Center for Radiology and Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference50 articles.

1. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria;Dubois;Lancet Neurol,2007

2. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement,2011

3. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;McKhann;Alzheimers Dement,2011

4. Value of CSF beta-amyloid(1-42) and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment;Hampel;Molecular Psychiatry,2004

5. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment;Tabert;Arch Gen Psychiatry,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk, protective, and biomarkers of dementia in Indigenous peoples: A systematic review;Alzheimer's & Dementia;2023-09-25

2. Alzheimer’s disease detection using artificial intelligence;Augmenting Neurological Disorder Prediction and Rehabilitation Using Artificial Intelligence;2022

3. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-05

4. Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease;Life Sciences, Society and Policy;2020-10-12

5. Neuroimaging Findings in Mild Cognitive Impairment;PET and SPECT in Neurology;2020-10-11